Fort Lauderdale, FL, July 12, 2017 -- Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to healthcare companies, is pleased to announce its role as the exclusive financial advisor to Omni Eye Services and its affiliates (“Omni Eye Services” or “Omni”) on their partnership with New MainStream Capital, a private investment firm specializing in strategic equity investments of lower middle market companies in selected growth industries. The transaction was led by Cross Keys’ Co-Founder and Managing Director Bill Britton and Director Marjorie Chang.
Founded in 1998, Omni is an optometric referral practice providing a full range of specialty services for the advanced treatment of eye diseases through a network of six offices, including one which operates an ophthalmology-focused ambulatory surgery center, throughout New Jersey and New York. With more than 26 board-certified ophthalmologists and residency-trained optometrists supported by a staff of more than 150 registered nurses, ophthalmic technicians, surgical technicians, and patient services representatives, Omni provides over 75,000 patient encounters annually.
“While we initially selected Cross Keys due to their team’s knowledge and experience with similar physician groups, it was their consistent guidance that was invaluable in aligning our group with the ideal partner to help us build on the practice we have established and also retain the culture of our organization. The team at Cross Keys was unwavering in their commitment to our shareholders, our practice, as well as our personal and corporate goals, shepherding us through the process to the consummation of our exciting new partnership,” explained Dr. Christopher Quinn, President and Co-Founder of Omni Eye Services.
Bill Britton, Co-Founder of Cross Keys and leader of the firm’s healthcare division adds, “The dedicated team at Omni Eye Services has built a highly-regarded ophthalmology practice, widely recognized throughout the referring optometric community for their reputation of delivering efficient, high-quality specialized eye care. We expect the partnership with New MainStream Capital will be a win-win, enabling Omni to increase the reach of their services to a greater patient population within the region and driving the growth of the business.”
“Their commitment to the consultation and co-management model of eye care fosters a cooperative relationship among providers within the community,” added Mr. Britton. “We are excited for the prospect of Omni’s growth in the future and how this will enhance the delivery of quality eye care.”
“From the beginning, I always felt as though Cross Keys had our best interests in mind. Their team played a key role in bringing this partnership to a successful fruition,” added Dr. Quinn.
About Omni Eye Services
Omni is an optometric referral practice providing a full range of specialty services for the advanced treatment of eye diseases, based in Iselin, NJ. Omni, by design, offers no primary care optometric services, but promotes a partnership between optometry and ophthalmology to deliver exceptional vision care. Founded in 1998, Omni provides eye care services through a network of six offices, including one which operates an ophthalmology-focused ambulatory surgery center, throughout New Jersey and New York.
For additional information on Omni, visit omnieyeservices.com
About New MainStream Capital
New MainStream Capital is a New York-based private investment firm specializing in strategic equity investments and leveraged buyouts of lower middle market companies. The firm was formed through the spin-out of a group of portfolio companies from the Goldman Sachs Merchant Banking Division. NMS focuses on companies headquartered in the U.S. poised to benefit from sustainable growth trends with particular concentration on companies in Healthcare Services and Specialized Business Services.
For additional information on NMS, visit nms-capital.com.
About Cross Keys Capital, LLC
Cross Keys Capital, LLC is a leading independent investment bank providing merger and acquisition advisory services to established businesses in the middle market, in areas including healthcare, business services, niche manufacturing, and information technology. The firm’s healthcare practice is a leader in representing vision and eye care practices and other private physician group practices including anesthesiology, radiology, ED, pathology, hospitalists, dermatology, as well as a variety of healthcare service providers and healthcare technology companies. The firm’s extensive experience and track record in advising physician practices are unrivaled by any other middle-market investment banking firm in the nation – Cross Keys has completed the sale or merger of over fifty transactions of independent physician group practices, healthcare providers, services, and technology companies.
For more information on Cross Keys Capital’s perspectives on Healthcare M&A and the sale of physician practices, visit crosskeyscapital.com or contact Bill Britton at (954) 779‐3195 and at [email protected].


SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
First Western Ship Transits Strait of Hormuz Since Iran War Began
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 



